Chiasma Inc (CHMA.OQ)
CHMA.OQ on NASDAQ Stock Exchange Global Select Market
3.98USD
21 Feb 2019
3.98USD
21 Feb 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$3.98
$3.98
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
15,628
15,628
52-wk High
$4.81
$4.81
52-wk Low
$1.20
$1.20
About
Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $70.64 |
| Shares Outstanding(Mil.): | 24.36 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CHMA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.48 | 33.70 |
| EPS (TTM): | -1.28 | -- | -- |
| ROI: | -34.47 | 14.95 | 14.45 |
| ROE: | -35.41 | 16.27 | 15.96 |
Estimates